Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Defibtech, SCAA to launch automated external defibrillator effort

Defibtech and the Sudden Cardiac Arrest Association (SCAA) have launched an effort to provide automated external defibrillators (AEDs) to communities with critical needs.

FDA injunction stops Medtronic from making, selling some defibrillators

 Top executives of Physio-Control and its parent company Medtronic havesigned a consent decree of permanent injunction issued by the FDArelated to automatic external defibrillators (AED) manufactured byPhysio-Control.

Home AEDs do not improve survival rate of post-MI patients

For survivors of anterior-wall MI who were not candidates for implantation of a cardioverter–defibrillator, access to a home automated external defibrillator (AED) did not significantly improve survival, compared with reliance on conventional resuscitation methods, according to results from the Home Automated External Defibrillator Trial (HAT) presented Tuesday by Gust H. Bardy, MD, at the 2008 American College of Cardiology (ACC) Scientific Sessions in Chicago.

BMJ: Calcium supplements may lead to cardiovascular events in older women

Calcium supplementation in healthy postmenopausal women is associatedwith upward trends in cardiovascular event rates, according to a studypublished online Jan. 15 in BMJ.

Study results show Vytorin not effective for lowering family linked high cholesterol

  Despite catchy TV commercials claiming Vytorin's positives of reducingcholesterol levels in patients predisposed to high cholesterol levels,a just-released study found Vytorin is no more effective in treatingpatients who were genetically predisposed to having dangerously highlevels of cholesterol than Merck's drug Zocor (Vytorin contains Zocor)because it did not slow the growth of artery blockages.

Circulation: Out-of-hospital cardiac arrest survival rates similar after standard CPR or chest compr

A simpler version of bystander-delivered cardiopulmonary resuscitation (CPR) that skips mouth-to-mouth resuscitation may be just as effective for out-of-hospital cardiac arrest victims as standard CPR, according to two studies published online on Dec. 18 in Circulation: Journal of the American Heart Association.

Statins Work But Pharmacoeconomic Caveats Abound

Cardiologists need to weigh the benefits of the more efficacious branded statins in comparison to the less expensive generics.

Report: Defibrillator use on the rise in Europe

For smaller companies to enter the burgeoning defibrillator market,they should forge alliances with businesses that can help them improvesales, distribution and market share, according to market research firmFrost & Sullivan.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.